In the long human effort to understand why the same illness spares some and devastates others, researchers at King's College London and the Medical University of Vienna have found a partial answer written in the blood itself. By screening over three thousand proteins through a genetic lens, they identified fourteen with causal links to COVID-19 severity — six that heighten risk and eight that protect — with the ABO enzyme, the very protein that determines blood type, emerging as a key driver of hospitalization and death. The work marks a meaningful turn in pandemic science: from observation to
News18
· Mar 04, 2022
· health
· 2 min de lectura
High
Verificación: Verificado
Study Links Blood Groups to Severe COVID-19 Risk Through Protein Analysis
◉
Health & Medicine
7994 artículos relacionados
Dr. Reddy's Wins Semaglutide Approval as Novo Nordisk Patent Challenge…
NDTV Profit · 100% coincidencia
EU safety committee reviews reports of menstrual changes after mRNA CO…
CNBC · 99% coincidencia
Canada faces new COVID epidemic, not third wave, as variants target di…
The Globe and Mail · 99% coincidencia
Researchers identify new Ebola variant, propose repurposed drug treatm…
Medical Xpress · 99% coincidencia
Dalhousie researchers identify new Ebola variant, propose repurposed d…
Education News Canada · 99% coincidencia
Cobertura Relacionada
The Guardian · Aug 18
ADHD diagnosis surge raises questions about identity versus disorder
Experts warn that rising ADHD diagnoses increasingly reflect identity-seeking rather than medical need, with poor-qualit…
BBC News · Aug 18 BBC investigation expands: 30 children feared conceived with wrong donors at Cyprus IVF clinicsAt least 30 children, mostly British, are feared conceived via IVF in northern Cyprus using wrong sperm or egg donors th…
News-Medical · Aug 18 IV Iron Use Among Australian Women Surges 17-Fold in DecadeAustralian women's intravenous iron use jumped 17-fold in a decade, with 1 in 20 reproductive-age women receiving treatm…
geneonline.com · Aug 18 1 in 20 Australian Women Now Receiving IV Iron InfusionsOne in 20 Australian women now receive intravenous iron infusions, marking a significant decade-long increase in this tr…
Sesgo y Encuadre
No hay datos de análisis detallado para esta lente. Intenta volver a ejecutar las lentes desde el panel de administración.
Impacto Geopolítico
🌎
Medical research on COVID-19 protein markers has no direct geopolitical implications; findings are scientific and applicable globally without affecting international power dynamics.
Escalation Risk
low
Confidence
HIGH
No shifts in power, alliances, or influence. This is a medical research publication with universal scientific application.
Lente Económico
📈
Research identifying blood group proteins linked to COVID-19 severity could enable targeted therapeutics, potentially reducing hospitalization costs and improving healthcare resource allocation.
Market Signal
bullish
Confidence
MED
Pharmaceutical and Biotechnology
Healthcare and Hospitals
Diagnostics and Testing
Medical Research and Development
Consumers may benefit from personalized risk assessments based on blood type and access to preventive treatments. Could reduce hospitalization rates and associated out-of-pocket medical expenses for vulnerable populations.
Potential regulatory pathways for accelerated drug approval targeting identified proteins; public health agencies may incorporate blood group screening into COVID-19 risk stratification protocols; healthcare systems could optimize resource allocation based on genetic risk profiles.